It has become an increasing challenge to attend medical and scientific conferences and remain abreast of clinically-relevant advances and their impact on daily clinical practice. With a Canadian panel perspective, this program delivers key highlights from three important Fall conferences.
Expert Review 2011: EACS, HIV and Aging, AASLD (Liver Meeting)
with Mark A. Wainberg, PhD, Dr. Frederic Crouzat, Alice Tseng, B.Sc.Phm. and Dr. Stephan D. Shafran
13th European AIDS Conference
- STARTMRK 192
- VIKING 24
- ATL to CTL
- TDR in MSM
HIV and Aging
- Premature age-related comorbidities
- CVD and dementia
- Falls: prevalence and risk factors
- Aging challenges
The Liver Meeting (AASLD)
- Study 110
- PSI-7977 PROTON
- PSI-7977 ELECTRON
- DAA Combination Therapy
This activity is supported by an educational grant from:
Mark A. Wainberg, PhD
McGill AIDS Centre
Professor of Medicine
Frederic Crouzat, CCFP
Maple Leaf Medical Clinic
Alice Tseng, B.Sc.Phm., Pharm.D., FCSHP, AAHIVP
HIV Pharmacotherapy Specialist
Toronto General Hospital
Leslie Dan Faculty of Pharmacy
University of Toronto
Stephan D. Shafran, MD, FRCPC, FACP
Division of Infectious Diseases
University of Alberta
Focus on EACS 2011
Focus on HIV and Aging 2011
Focus on AASLD 2011
ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Mark A. Wainberg, PhD currently has no financial interests/relationships or affiliations in relation to this activity.
Alice Tseng, B.Sc.Phm., Pharm.D., FCSHP, AAHIVP has a financial interest/relationship or affiliation:
(2009-2011) Unrestricted educational grants: Merck, Janssen, ViiV, Abbott; lectures: Abbott, Merck, ViiV; conference sponsorships: Janssen, Merck, Abbott.
Frederic Crouzat, CCFP has a financial interest/relationship or affiliation:
Abbott, Boehringer Ingelheim, BMS, Gilead, GlaxoSmithKline, Lilly, Merck, Pfizer, Solvay, Tibotec, ViiV.
Stephan D. Shafran, MD, FRCPC, FACP has a financial interest/relationship or affiliation:
Abbott, BMS, Boehringer Ingelheim, Gilead, GSK, Janssen, Pfizer, Roche, Vertex.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.